Back to Newsroom
Back to Newsroom

Applied UV Continues International Expansion with Airocide(R) Installation in South Korean Schools

Monday, 13 September 2021 08:30 AM

Applied UV, Inc.

Installations in nearly 100 school dedicated observation rooms
Airocide® technology helps schools reopen safely and allow for the safe return to campus

MOUNT VERNON, NY / ACCESSWIRE / September 13, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that its Southeast Asia distributor has installed Airocide® units in nearly 100 schools that have created designated observation rooms where students are required to stay for a certain period prior to seeing a school nurse. With more than 18,000 K-12 facilities and close to 350 universities in South Korea, Applied UV expects that these installations will serve as a platform for the expansion of the Airocide® solution into additional areas located with school facilities to include nurses' rooms, cafeterias, kitchens, and classrooms at a time when face-to-face classes are fully allowed.

"These significant installations in South Korea follow on our recently announced awards of Airocide® units at schools located in Uruguay and Switzerland and illustrate the urgent challenges faced by schools globally as a result of COVID-19," said Q Saeed, CEO of Applied UV. "With the beginning of the new school year underway, administrators must try to balance education and safety as they navigate disparate reopening guidelines, data and community pressures. The Airocide® air pathogen control technology provides a clinically proven solution to help protect students and staff by destroying dangerous pathogens and allow for a safer return to campus."

Airocide® utilizes NASA optimized photocatalytic oxidation ("PCO") technology wherein air and any contaminants are drawn from the room into the Airocide® unit and channeled into the reaction chamber. UVC activates the proprietary photocatalyst embedded in the reaction chamber, beginning the photocatalytic process. In the reaction chamber, hydroxyl radicals and super-oxide ions are generated and oxidize every organic molecule that comes in contact. The reaction bed is designed to allow the surface-bound radicals nearly three hundred and sixty degrees of exposure for maximum likelihood of collisions with pathogens and other organic material. Millions of hydroxyl radicals converge, combining with the carbon atoms in pathogens (airborne bacteria, mold, fungi, mycotoxins, viruses, allergens) and VOCs, converting the organic material into a harmless vapor and clean, clear air.

Airocide® System

The Airocide® System, originally developed by NASA with assistance from the University of Wisconsin at Madison, is an airborne pathogen killing technology that uses a patented combination of UVC and a proprietary, titanium dioxide based photocatalyst. Listed as an FDA Class II Medical device, the Airocide® technology is clinically proven and field tested to kill/remove/eliminate airborne pathogenic and non-pathogenic microorganisms, allergens, odors and harmful VOCs in a variety of applications and industries including healthcare, hospitality, grocery chains, wineries, commercial real estate, schools, dental offices and homes. Airocide® air purifiers are available at www.airocide.com

About Applied UV

Applied UV is focused on the development and acquisition of technology that address infection control in the healthcare, hospitality, commercial and municipal markets. The Company has two wholly owned subsidiaries - SteriLumen, Inc. ("SteriLumen") and Munn Works, LLC ("Munn Works"). SteriLumen's connected platform for Data Driven Disinfection™ applies the power of ultraviolet light (UVC) to destroy pathogens safely, thoroughly, and automatically, addressing the challenge of healthcare-acquired infections ("HAIs"). Targeted for use in facilities that have high customer turnover such as hospitals, hotels, commercial facilities, and other public spaces, the Company's Lumicide™ platform uses UVC LEDs in several patented designs for infection control in and around high-traffic areas, including sinks and restrooms, killing bacteria, viruses, and other pathogens residing on hard surfaces within devices' proximity. The Company's patented in-drain disinfection device, Lumicide Drain, is the only product on the market that addresses this critical pathogen intensive location. SteriLumen's Airocide® products for air purification, developed by NASA and FDA Cleared as class II medical devices, utilize a proprietary photo-catalytic bioconversion technology that draws air into a reaction chamber that converts damaging molds, microorganisms, dangerous pathogens, destructive VOCs and biological gasses into harmless water vapor without producing ozone or other harmful byproducts. Airocide® applications include healthcare, hospitality, grocery chains, wine making facilities, commercial real estate, schools, dental offices, and homes.

For more information about Applied UV, Inc., and its subsidiaries, please visit the following websites: https://www.applieduvinc.com/; https://sterilumen.com/; and, https://munnworks.com/.

Forward-Looking Statements

The information contained herein may contain "forward‐looking statements." Forward‐looking statements reflect the current view about future events. When used in this press release, the words "anticipate," "believe," "estimate," "expect," "future," "intend," "plan," or the negative of these terms and similar expressions, as they relate to us or our management, identify forward‐looking statements. Such statements include, but are not limited to, statements contained in this press release relating to the view of management of Applied UV concerning its business strategy, future operating results and liquidity and capital resources outlook. Forward‐looking statements are based on the Company's current expectations and assumptions regarding its business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company's actual results may differ materially from those contemplated by the forward‐looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward‐looking statements. Factors or events that could cause the Company's actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. The Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward‐looking statements to conform these statements to actual results.

CONTACT:
Applied UV Investor Relations
Kevin McGrath
TraDigital IR
+1-646-418-7002
[email protected]

SOURCE: Applied UV, Inc.

Topic:
Company Update
Back to newsroom
Back to Newsroom
Share by: